These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 16061659
21. Antioxidants prevent oxidative DNA damage and cellular transformation elicited by the over-expression of c-MYC. K C S, Cárcamo JM, Golde DW. Mutat Res; 2006 Jan 29; 593(1-2):64-79. PubMed ID: 16085125 [Abstract] [Full Text] [Related]
23. Genistein protects prostate cells against hydrogen peroxide-induced DNA damage and induces expression of genes involved in the defence against oxidative stress. Raschke M, Rowland IR, Magee PJ, Pool-Zobel BL. Carcinogenesis; 2006 Nov 29; 27(11):2322-30. PubMed ID: 16774941 [Abstract] [Full Text] [Related]
28. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells. Wang P, Liu B, Luo JD, Zhang ZG, Ma Q, Chen ZD. Asian J Androl; 2007 May 29; 9(3):353-60. PubMed ID: 17486276 [Abstract] [Full Text] [Related]
29. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Bavik C, Coleman I, Dean JP, Knudsen B, Plymate S, Nelson PS. Cancer Res; 2006 Jan 15; 66(2):794-802. PubMed ID: 16424011 [Abstract] [Full Text] [Related]
30. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL, Bethel C, Lotz MT, Yegnasubramanian S, Nelson WG, Dang CV, Xu M, Anele U, Koh CM, Bieberich CJ, De Marzo AM. PLoS One; 2010 Feb 25; 5(2):e9427. PubMed ID: 20195545 [Abstract] [Full Text] [Related]
31. Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis. Cappello F, Rappa F, David S, Anzalone R, Zummo G. Anticancer Res; 2003 Feb 25; 23(2B):1325-31. PubMed ID: 12820390 [Abstract] [Full Text] [Related]
36. Transgenic mouse with human mutant p53 expression in the prostate epithelium. Elgavish A, Wood PA, Pinkert CA, Eltoum IE, Cartee T, Wilbanks J, Mentor-Marcel R, Tian L, Scroggins SE. Prostate; 2004 Sep 15; 61(1):26-34. PubMed ID: 15287091 [Abstract] [Full Text] [Related]
37. Constitutive expression of the human peroxiredoxin V gene contributes to protection of the genome from oxidative DNA lesions and to suppression of transcription of noncoding DNA. Kropotov A, Serikov V, Suh J, Smirnova A, Bashkirov V, Zhivotovsky B, Tomilin N. FEBS J; 2006 Jun 15; 273(12):2607-17. PubMed ID: 16817890 [Abstract] [Full Text] [Related]
38. Angiotensin II induces oxidative stress in prostate cancer. Uemura H, Ishiguro H, Ishiguro Y, Hoshino K, Takahashi S, Kubota Y. Mol Cancer Res; 2008 Feb 15; 6(2):250-8. PubMed ID: 18314486 [Abstract] [Full Text] [Related]
39. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor. Ju JH, Maeng JS, Zemedkun M, Ahronovitz N, Mack JW, Ferretti JA, Gelmann EP, Gruschus JM. J Mol Biol; 2006 Jul 28; 360(5):989-99. PubMed ID: 16814806 [Abstract] [Full Text] [Related]